Nevertheless, exogenous ghrelin infusion has been shown to surpass this barrier by increasing blood glucose in humans of either weight status, with greater blood glucose increments occurring in particular among those with obesity [47]. The gene discussed is GHRL; the disease is obesity due to melanocortin 4 receptor deficiency.